Fundraising Fox

DermBiont

Boston, US · Founded 2016 · Delaware corporation · 7 known investors

dermbiont.com ↗

DermBiont develops SM-030, a topical drug candidate targeting melasma, a skin pigmentation disorder, by inhibiting PKC-beta to address the underlying cause of hyperpigmentation.

BiotechDigital HealthMedical Devicesin /dermbiont

Founders & leadership

KR
Karl R. BeutnerExecutive Officer, Director
NE
Nichola EliovitsExecutive Officer, Director
MD
Max DawsonExecutive Officer
JL
Jennifer LeeDirector
RB
Robert BruckerExecutive Officer
WR
Wilder RamseyDirector
DY
Daniel YadegarDirector
SB
Steven BastaDirector

Investors · 7

Civilization Ventures Management, LlcTiburon · $1M – $10M
Joyance PartnersBerlin
Olive Tree CapitalBoston
Start Capital
Toba CapitalIrvine · $1M – $10M
Valia VenturesLondon · $50K – $50M
Newpath PartnersreportedBoston · $50K – $10Mvia Daniel Yadegar · board

Reported raises · per SEC filings

Form D private placements
▶$32.7MraisedNov 2024 · 72 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel YadegarDirector
  • Steven BastaDirector
  • Karl R. BeutnerExecutive Officer, Director
  • Nichola EliovitsExecutive Officer, Director
  • Max DawsonExecutive Officer
  • Wilder RamseyDirector
Offering amount
$45.3M
Amount sold
$32.7M
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedMar 2023 · 69 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Karl R. BeutnerExecutive Officer, Director
  • Wilder RamseyDirector
  • Max DawsonExecutive Officer
  • Steven BastaDirector
  • Jennifer LeeDirector
  • Nichola EliovitsExecutive Officer, Director
Offering amount
$4.7M
Amount sold
$4.7M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedSep 2022 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven BastaDirector
  • Wilder RamseyDirector
  • Karl R BeutnerExecutive Officer, Director
  • Jennifer LeeDirector
  • Max DawsonExecutive Officer
  • Nichola EliovitsExecutive Officer, Director
Amount sold
$2.5M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$830.3KraisedJan 2022 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Max DawsonExecutive Officer
  • Nichola EliovitsExecutive Officer, Director
  • Jennifer LeeDirector
  • Karl R. BeutnerExecutive Officer, Director
  • Ramsey WilderDirector
  • Steven BastaDirector
Offering amount
$830.3K
Amount sold
$830.3K
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.8MraisedDec 2021 · 42 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wilder RamseyDirector
  • Nichola EliovitsExecutive Officer
  • Steven BastaDirector
  • Max DawsonExecutive Officer
  • Jennifer LeeDirector
  • Karl R. BeutnerExecutive Officer, Director
Offering amount
$39.5M
Amount sold
$28.8M
First sale
Dec 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.2MraisedAug 2021 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven BastaDirector
  • Jennifer LeeDirector
  • Wilder RamseyDirector
  • Karl R. BeutnerExecutive Officer, Director
  • Robert BruckerExecutive Officer
  • Nichola EliovitsExecutive Officer, Director
Offering amount
$19.2M
Amount sold
$19.2M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.6MraisedFeb 2021 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wilder RamseyDirector
  • Steven BastaDirector
  • Nichola EliovitsExecutive Officer, Director
  • Robert BruckerExecutive Officer
  • Karl R. BeutnerExecutive Officer, Director
Offering amount
$15M
Amount sold
$6.6M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.2MraisedOct 2020 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wilder RamseyDirector
  • Robert BruckerExecutive Officer
  • Nichola EliovitsExecutive Officer, Director
  • Steven BastaDirector
  • Karl R. BeutnerExecutive Officer, Director
Offering amount
$8M
Amount sold
$7.2M
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.